Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
11.7 USD | +4.00% |
|
-.--% | -.--% |
06-19 | Transcript : Santhera Pharmaceuticals Holding AG - Special Call | |
06-18 | Santhera Secures CHF69 Million Financing for Bond Repayment, Cash Runway Extension | MT |
Chart calendar Santhera Pharmaceuticals Holding AG
Upcoming events on Santhera Pharmaceuticals Holding AG
Past events on Santhera Pharmaceuticals Holding AG
19/06/2024 13:00 | Business Update Call |
18/06/2024 09:00 | Annual General Meeting |
25/04/2024 13:30 | Q4 2023 Earnings Call |
25/04/2024 06:00 | Q4 2023 Earnings Release |
02/10/2023 | World Muscle Society Congress |
12/09/2023 15:00 | H.C. Wainwright Global Investment Conference |
07/09/2023 13:30 | Q2 2023 Earnings Call |
07/09/2023 06:00 | Q2 2023 Earnings Release |
02/07/2023 | Reverse Split: 1 of 10 |
28/06/2023 | PPMD Conference |
27/06/2023 09:00 | Annual General Meeting |
27/04/2023 13:30 | Q4 2022 Earnings Call |
27/04/2023 06:00 | Q4 2022 Earnings Release |
18/03/2023 | MDA Clinical & Scientific Conference |
29/11/2022 09:30 | Extraordinary Shareholders Meeting |
07/11/2022 13:30 | Interim 2022 Earnings Call |
31/10/2022 06:00 | Interim 2022 Earnings Release |
14/10/2022 18:40 | World Muscle Society Congress - Poster : #FP.27 |
14/10/2022 18:30 | World Muscle Society Congress - Poster : #P.133 |
12/10/2022 20:00 | World Muscle Society Congress - Poster : #P.71 |
Annual results
Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|
Net sales Million CHF | Released Forecast Spread | 75,4 76,1 -0.95% | 15,0 15,0 0.05% | -1,60 8,00 -119.94% | 7,47 0,00 - | 103 8,29 1147% | 24,0 |
EBITDA Million CHF | Released Forecast Spread | -5,67 -1,92 -195.13% | -45,9 -42,0 -9.38% | -39,6 -25,0 -58.26% | -42,1 -35,0 -20.34% | 0,00 0,00 - | -27,0 |
EBIT Million CHF | Released Forecast Spread | -10,4 -5,30 -97.19% | -53,1 -51,5 -3.06% | -56,9 -29,0 -96.17% | -52,0 -39,0 -33.27% | 68,8 -48,0 243.32% | -30,0 |
Earnings before Tax (EBT) Million CHF | Released Forecast Spread | -18,4 0,41 -4597.31% | -67,5 -62,5 -7.93% | -54,7 -39,0 -40.3% | -69,7 -47,0 -48.27% | 0,00 0,00 - | -35,0 |
Net income Million CHF | Released Forecast Spread | -19,0 0,41 -4738.88% | -67,7 -71,0 4.71% | -55,5 -39,0 -42.37% | -70,1 -47,0 -49.25% | 0,00 0,00 - | -35,0 |
EPS CHF | Released Forecast Spread | -17,3 0,37 -4775.68% | -50,8 -42,3 -20.09% | -16,2 -7,20 -125% | -11,7 -6,30 -85.71% | 0,00 0,00 - | -2,81 |
Announcement Date | 24/03/20 | 29/04/21 | 10/06/22 | 27/04/23 | 25/04/24 | - |
Quarterly results
Fiscal Period | December | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
---|---|---|---|---|---|---|---|---|---|
Net sales Million CHF | Released Forecast Spread | 1,85 | 1,99 | 2,05 | 2,40 | 5,70 | 10,3 | 13,7 | 21,4 |
EBIT Million CHF | Released Forecast Spread | -10,5 | -11,5 | -12,6 | -13,5 | ||||
Announcement Date | - | - | - | - | - | - | - | - |
Past sector events for Santhera Pharmaceuticals Holding AG
23/05/2024 06:00 | CALLIDITAS THERAPEUTICS AB: Q1 2024 Earnings Release |
15/05/2024 06:00 | MERCK KGAA: Q1 2024 Earnings Release |
13/05/2024 | OSCOTEC INC.: Q1 2024 Earnings Release |
13/05/2024 | MEZZION PHARMA CO.,LTD.: Q1 2024 Earnings Release |
08/05/2024 | SK BIOPHARMACEUTICALS CO., LTD.: Q1 2024 Earnings Release |
08/05/2024 21:05 | SUPERNUS PHARMACEUTICALS, INC.: Q1 2024 Earnings Release |
06/05/2024 | KISSEI PHARMACEUTICAL CO., LTD.: Q4 2023 Earnings Release |
06/05/2024 | KYOWA KIRIN CO. LTD.: Q1 2024 Earnings Release |
29/04/2024 | YOUCARE PHARMACEUTICAL GROUP CO., LTD.: Q4 2023 Earnings Release |
29/04/2024 | HK INNO.N CORPORATION: Q1 2024 Earnings Release |
Net sales - Quarter - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- SANN Stock
- SPHDF Stock
- Calendar Santhera Pharmaceuticals Holding AG